2-61825355-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001201543.2(FAM161A):c.*1100T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 454,192 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0090 ( 4 hom., cov: 32)
Exomes 𝑓: 0.011 ( 32 hom. )
Consequence
FAM161A
NM_001201543.2 3_prime_UTR
NM_001201543.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.374
Genes affected
FAM161A (HGNC:25808): (FAM161 centrosomal protein A) This gene belongs to the FAM161 family. It is expressed mainly in the retina. Mouse studies suggested that this gene is involved in development of retinal progenitors during embryogenesis, and that its activity is restricted to mature photoreceptors after birth. Mutations in this gene cause autosomal recessive retinitis pigmentosa-28. Alternatively spliced transcript variants have been identified.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-61825355-A-G is Benign according to our data. Variant chr2-61825355-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 336719.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00902 (1374/152266) while in subpopulation NFE AF= 0.0144 (979/68022). AF 95% confidence interval is 0.0136. There are 4 homozygotes in gnomad4. There are 621 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAM161A | NM_001201543.2 | c.*1100T>C | 3_prime_UTR_variant | 7/7 | ENST00000404929.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAM161A | ENST00000404929.6 | c.*1100T>C | 3_prime_UTR_variant | 7/7 | 1 | NM_001201543.2 | P1 | ||
FAM161A | ENST00000405894.3 | c.*1100T>C | 3_prime_UTR_variant | 6/6 | 1 | ||||
FAM161A | ENST00000456262.5 | c.*2598T>C | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 1 | ||||
FAM161A | ENST00000418113.5 | c.*1723T>C | 3_prime_UTR_variant, NMD_transcript_variant | 8/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00904 AC: 1375AN: 152148Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
1375
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00892 AC: 1165AN: 130616Hom.: 7 AF XY: 0.00924 AC XY: 659AN XY: 71296
GnomAD3 exomes
AF:
AC:
1165
AN:
130616
Hom.:
AF XY:
AC XY:
659
AN XY:
71296
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0109 AC: 3300AN: 301926Hom.: 32 Cov.: 0 AF XY: 0.0109 AC XY: 1869AN XY: 172068
GnomAD4 exome
AF:
AC:
3300
AN:
301926
Hom.:
Cov.:
0
AF XY:
AC XY:
1869
AN XY:
172068
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00902 AC: 1374AN: 152266Hom.: 4 Cov.: 32 AF XY: 0.00834 AC XY: 621AN XY: 74480
GnomAD4 genome
AF:
AC:
1374
AN:
152266
Hom.:
Cov.:
32
AF XY:
AC XY:
621
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3470
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Retinitis pigmentosa Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | FAM161A: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at